Physician profile
Mladen Vidovich
NPI 1952350621
$12,013.96
in general payments reported to CMS, 2019-2025
25 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,084 · 2020: $412 · 2021: $2,663 · 2022: $3,208 · 2023: $2,983 · 2024: $1,395 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,031 · Consulting Fee: $1,555 · Education: $62.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,030.55 |
| Consulting Fee | $1,555.00 |
| Education | $62.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,048.61 | 2021-2024 | Onyx Frontier, Symplicity G3, Micra |
| Boston Scientific Corporation | $2,900.57 | 2020-2025 | Avvigo Guidance System, Stingray, Opticross |
| Ge Healthcare | $855.00 | 2023 | |
| Inari Medical, INC. | $751.34 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $518.42 | 2019-2020 | |
| Cordis US Corp. | $516.70 | 2023-2024 | Mynx Venous Vcd |
| Biotronik INC. | $412.03 | 2019-2025 | |
| Abiomed | $404.48 | 2023-2024 | Impella |
| Cardiovascular Systems INC. | $205.37 | 2019-2020 | |
| Merit Medical Systems INC | $200.00 | 2023 | |
| Shockwave Medical, INC | $188.89 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $153.83 | 2019-2023 | Diamondback Coronary |
| Kowa Pharmaceuticals America, INC. | $131.61 | 2019 | |
| Philips North America LLC | $123.34 | 2020-2022 | |
| Cardinal Health 200 LLC | $117.44 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $101.30 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Surmodics, INC. | $97.02 | 2021-2024 | Pounce Thrombectomy |
| Edwards Lifesciences Corporation | $92.17 | 2024 | Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $62.01 | 2023 | Kengreal |
| Cvrx, INC. | $59.20 | 2024 | Barostim Neo System |
| Teleflex LLC | $30.76 | 2025 | Orsiro Mission |
| Angiodynamics, INC. | $24.00 | 2023 | Alphavac |
| Terumo Medical Corporation | $19.87 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mladen Vidovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.